1. Home
  2. SVM vs SUPN Comparison

SVM vs SUPN Comparison

Compare SVM & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silvercorp Metals Inc.

SVM

Silvercorp Metals Inc.

HOLD

Current Price

$8.22

Market Cap

2.1B

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$41.83

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SVM
SUPN
Founded
2003
2005
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.5B
IPO Year
2005
2010

Fundamental Metrics

Financial Performance
Metric
SVM
SUPN
Price
$8.22
$41.83
Analyst Decision
Buy
Buy
Analyst Count
6
4
Target Price
$14.50
★ $60.50
AVG Volume (30 Days)
★ 1.8M
839.6K
Earning Date
11-05-2026
10-29-2026
Dividend Yield
★ 0.29%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $392,755,000.00
Revenue This Year
$3.19
$21.56
Revenue Next Year
$74.89
$55.45
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$5.97
$37.54
52 Week High
$15.77
$59.68

Technical Indicators

Market Signals
Indicator
SVM
SUPN
Relative Strength Index (RSI) 28.05 49.95
Support Level N/A $37.54
Resistance Level $13.53 $51.59
Average True Range (ATR) 0.38 1.93
MACD -0.09 0.15
Stochastic Oscillator 2.90 61.67

Price Performance

Historical Comparison
SVM
SUPN

About SVM Silvercorp Metals Inc.

Silvercorp Metals Inc is engaged in the acquisition, exploration, development, and mining of mineral properties. The Company's producing mines are located in China, and current exploration and development projects are located in China, Ecuador and Kyrgyz Republic. The company operates in single segment. The Company mainly produces and sells silver, lead, zinc, gold and other metals. The company's producing projects are Ying Mining District, GC Mine; construction projects are El Domo; permitting project is BYP Mine; development project includes Condor, Tulkubash/Kyzyltash.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: